Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, Institute of Medicine (U.S.). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, ebrary, Inc, & Wizemann, T. M. (2011). Public health effectiveness of the FDA 510(k) clearance process: Balancing patient safety and innovation : workshop report. National Academies Press.
I tāruatia paitia ki te papatopenga
Kua rahua te tārua ki te papatopenga
Tohutoru Kātū Chicago (17th ed.)
Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, Institute of Medicine (U.S.). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Inc ebrary, me Theresa M. Wizemann. Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation : Workshop Report. Washington, D.C.: National Academies Press, 2011.
I tāruatia paitia ki te papatopenga
Kua rahua te tārua ki te papatopenga
Tohutoro MLA (9th ed.)
Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, et al. Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation : Workshop Report. National Academies Press, 2011.
I tāruatia paitia ki te papatopenga
Kua rahua te tārua ki te papatopenga
Kia tūpato: Kāore pea ēnei kupu hautoa i te ōrite pū 100%.